Australia refuses to buy J&J vaccine due to AstraZeneca similarities, as both firms are scrutinized over blood clots

Australia has declined

Australia has declined to purchase a vaccine made by Johnson & Johnson, because its mechanism is similar to the one used in AstraZeneca’s jab. Both vaccines are currently being investigated for links to blood clots.

The Johnson & Johnson (J&J) vaccine is “an adenovirus vaccine, the same type of vaccine as the AstraZeneca vaccine,” a spokesperson for Australian Health Minister Greg Hunt said in a statement.

Continue reading